Randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive persons with variety two diabetes. Diabetologia 2008;51:40816 Simonson GD, Cuddihy RM, Reader D, Bergenstal RM. International Diabetes Center treatment of sort 2 diabetes glucose algorithm. Diabetes Management 2011;1:17589 Gross JL, Kramer CK, Leit CB, et al.; Diabetes and Endocrinology Meta-analysis Group (DEMA). Effect of antihyperglycemic agents added to metformin plus a sulfonylurea on glycemic handle and weightDIABETES CARE, VOLUME 35, JUNE67.80.68.81. 82.69. 70.83.71.84.72.85.73.74.86.75.87.76. 77.88.78.89.79.90.get in kind two diabetes: a network metaanalysis. Ann Intern Med 2011;154:672679 Karagiannis T, Paschos P, Paletas P, Matthews DR, Tsapas A. Dipeptidyl peptidase-4 inhibitors for form two diabetes mellitus within the clinical setting: systematic assessment and meta-analysis. BMJ 2012; 344:e1369 Cryer PE. Severe iatrogenic hypoglycemia in kind two diabetes mellitus. Nat Clin Pract Endocrinol Metab 2007;3:four Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones: systematic assessment and meta-analysis of observational studies. BMJ 2011;342:d1309 Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin-4) on glycemic manage more than 30 weeks in sufferers with sort two diabetes treated with metformin along with a sulfonylurea. Diabetes Care 2005;28:1083091 Zinman B, Gerich J, Buse JB, et al.; LEAD-4 Study Investigators. Efficacy and security with the human glucagon-like peptide-1 analog liraglutide in mixture with metformin and thiazolidinedione in individuals with variety 2 diabetes (LEAD-4 Met1TZD). Diabetes Care 2009;32:1224230 Roberts VL, Stewart J, Issa M, Lake B, Melis R. Triple therapy with glimepiride in sufferers with form 2 diabetes mellitus inadequately controlled by metformin along with a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2005;27: 1535547 Bell DS, Dharmalingam M, Kumar S, Sawakhande RB. Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study within the therapy of sophisticated kind two diabetes (Attempted study-II). Diabetes Obes Metab 2011;13:80005 Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G. Triple therapy in kind 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.Golimumab Diabetes Care 2006;29:55459 Yki-J vinen H, Juurinen L, Alvarsson M, et al.Proteinase K Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin mixture therapy in variety 2 diabetic individuals individually and in groups.PMID:24834360 Diabetes Care 2007;30:13641369 Davies M, Storms F, Shutler S, BianchiBiscay M, Gomis R; ATLANTUS Study Group. Improvement of glycemic handle in subjects with poorly controlled variety 2 diabetes: comparison of two remedy algorithms working with insulin glargine. Diabetes Care 2005;28:1282288 Garber AJ. The significance of titrating beginning insulin regimens in sufferers with91.92.93.94.95.96.97.98.99.100.101.102.variety 2 diabetes. Diabetes Obes Metab 2009;11(Suppl. five):103 Owens DR, Luzio SD, Sert-Langeron C, Riddle MC. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine when continuing titrated insulin glargine in form two diabetes: a 6-month `proof-of-concept’ study. Diabetes Obes Metab.
